vTv Therapeutics Inc. (Nasdaq: VTVT) shareholder Ronald O. Perelman purchased an additional 50,000 shares of company stock. Shares of the biopharmaceutical soared $1.51 to close at $5.56.
vTv Therapeutics shareholder acquires more stock
December 28, 2017 at 17:39 PM EST
